Originally published In Press as doi:10.1074/jbc.M206115200 on July 10, 2002
J. Biol. Chem., Vol. 277, Issue 38, 35202-35209, September 20, 2002
New Insights into the Role of the N Terminus in Conformational
Transitions of the Na,K-ATPase*
Laura
Segall
,
Lois K.
Lane§, and
Rhoda
Blostein
¶
From the
Department of Biochemistry, McGill
University, Quebec H3G 1A4, Canada and the § Department
of Pharmacology, University of Cincinnati College of Medicine,
Cincinnati, Ohio 45267-0575
Received for publication, June 19, 2002, and in revised form, July 9, 2002
 |
ABSTRACT |
The deletion of 32 residues from the N
terminus of the
1 catalytic subunit of the rat Na,K-ATPase (mutant
1M32) shifts the E1/E2 conformational
equilibrium toward E1, and the combination of this deletion
with mutation E233K in the M2-M3 loop acts synergistically to
shift the conformation further toward E1 (Boxenbaum, N.,
Daly, S. E., Javaid, Z. Z., Lane, L. K., and Blostein, R. (1998)
J. Biol. Chem. 273, 23086-23092). To delimit the
region of the cytoplasmic N terminus involved in these interactions,
the consequences of a series of N-terminal deletions of
1 beyond
32 were evaluated. Criteria to assess shifts in conformational
equilibrium were based on effects of perturbation of the entire
catalytic cycle ((i) sensitivity to vanadate inhibition, (ii)
K+ sensitivity of Na-ATPase measured at micromolar ATP,
(iii) changes in K'ATP, and (iv) catalytic turnover), as
well as estimates of the rates of the conformational transitions of
phospho- and dephosphoenzyme (E1P
E2P and
E2(K+)
E1 + K+).
The results show that, compared with
1M32, the deletion of up to 40 residues (
1M40) further shifts the poise toward E1. Remarkably, further deletions (mutants
1M46,
1M49, and
1M56) reverse the effect, such that these mutants increasingly resemble the
wild type
1. These results suggest novel intramolecular
interactions involving domains within the N terminus that impact the
manner in which the N terminus/M2-M3 loop regulatory domain interacts with the M4-M5 catalytic loop to effect E1
E2 transitions.
 |
INTRODUCTION |
The Na,K-ATPase or sodium pump is a ubiquitous integral membrane
protein that catalyzes the glycoside sensitive, ATP-coupled exchange of
three intracellular Na+ for two extracellular
K+ ions across the plasma membrane of all animal cells. The
sodium pump is essential to the maintenance of the electrochemical
gradients of Na+ and K+ across the cell
membrane, providing the driving force for the transport of nutrients
into the cell and maintaining the cellular resting membrane potential.
It comprises two essential subunits: a large catalytic
subunit
(~100 kDa), containing the ligand binding and phosphorylation sites
and a smaller, highly glycosylated
subunit (~35-55 kDa), which
acts as a chaperone for
(for review see Refs. 1 and 2). A third
subunit,
(~7 kDa), was found in the kidney where it functions as
a regulator of the pump (see Refs. 3 and 4).
The sodium pump is a member of a family of transporters known as P-type
ATPases that are directly phosphorylated and dephosphorylated on a
conserved aspartate residue within their cytoplasmic domain during the
course of the reaction cycle. Both the phosphorylated and
dephosphorylated forms of the enzyme can exist in at least two states
that undergo conformational transitions (E1P
E2P and E2
E1) that are coupled
to the ion-translocating steps. Definitive evidence for distinct
E1 and E2 conformational states and a role of
the N terminus in effecting E1
E2
transitions was first obtained in 1975 by Jorgensen (5, 6) using
tryptic cleavage of the renal enzyme in the presence of different
ligands. Later confirmatory evidence was obtained using N-terminal
deletion mutants expressed in cultured cells (7). This study showed that whereas deleting up to and including the lysine-rich cluster is
without effect, removal of 32 residues (mutant
1M32) alters the
enzyme kinetics by shifting the E1/E2
conformational equilibrium toward E1 forms. Interestingly,
a similar shift toward E1 is caused by Glu233
Lys substitution in the first (M2-M3) cytoplasmic loop.
Furthermore, the combined removal of the N-terminal 32 residues and
replacement of Glu233
Lys (mutant
1M32E233K) results
in a remarkably synergistic shift in poise toward E1
state(s) as evidenced in analyses of several characteristic properties
including, for examples, extraordinary insensitivity to vanadate, high
affinity for ATP (5 µM), and slow (
500
min
1) catalytic turnover of
1M32E233K. These findings
were interpreted to indicate that interactions between these two
cytoplasmic regions and the M4-M5 catalytic loop are critical for
conformational coupling (8).
The present study was carried out to define more precisely the
role of the N terminus in conformational transitions. Accordingly, we
investigated the consequences of further deletions of the N terminus of
the Na,K-ATPase beyond the first 32 residues to near the beginning of
the first transmembrane segment, using several criteria to assess
shifts in the steady-state E1
E2 poise. The results of this analysis reveal a progressively increased shift in the
E1/E2 poise toward E1,
followed by reversal toward the wild type
1
E1/E2 distribution. Combined with secondary
structure predictions of the N terminus, this behavior identifies a
self-regulatory domain within the N terminus of the Na,K-ATPase that
modulates conformational transitions via novel intramolecular interactions.
 |
EXPERIMENTAL PROCEDURES |
Determination of Helicity--
Predictions of the secondary
structure of the N-terminal sequence were evaluated using the following
algorithms: PREDATOR (9), Sspro (10), SOPMA (11), GOR IV (12), Deleage
and Roux (13), Levitt (14), Chou and Fasman (15), COILS v2.1 (16), and
PSA (17). Putative helical regions were then ascribed to those
sequences for which the above algorithms concur on helicity.
Mutagenesis, Transfection, Selection, and Cell Culture--
The
desired mutations were introduced into the 5'
SacI230-SalI875
restriction fragment cassette of the rat
1 cDNA as described previously (7). The mutant cassettes were then ligated into the rat
1 cDNA in the place of the wild type
SacI-SalI cassette. The full-length mutant
cDNAs were released form the shuttle vector by digestion with
HindIII, ligated into the expression plasmid pCDNA3.1
(Invitrogen), and orientation of the cDNA was determined by
restriction analysis. HeLa cells were transfected with the pCDNA-
1 mutant constructs using either the calcium phosphate method (18) or the LipofectAMINE technique (Invitrogen), and cells
expressing the relatively ouabain-resistant rat
1 enzymes and
mutants thereof were selected as described previously (19, 20). HeLa
cells expressing the mutant
1 enzymes were amplified in Dulbecco's
modified Eagle's medium plus 10% newborn calf serum, 100 units/mg
penicillin G, 100 µg/ml streptomycin, and 1 µM ouabain as described previously (7). The above medium was initially supplemented with an additional 15 mM KCl (20 mM total; see Ref. 21), which was removed after several passages.
Membrane Preparation--
NaI-treated microsomal membranes
were prepared from the mutant cells as described earlier (19, 20).
Protein content was determined with a detergent-modified Lowry assay
(22).
Enzyme Assays--
Na,K-ATPase activity was measured as the
release of 32Pi from [
-32P]ATP
as previously described (23). Briefly and unless indicated otherwise,
the membranes were preincubated for 10 min at 37 °C with all
reactants added except [
-32P]ATP. The reaction was
initiated by the addition of [
-32P]ATP. Final
concentrations for Na,K-ATPase activity measurements were 100 mM NaCl, 10 mM KCl, 3 mM
MgSO4, 20 mM histidine (pH 7.4), 5 mM EGTA (pH 7.4), and 5 µM ouabain (SIGMA). 5 mM ouabain was used to determine baseline hydrolysis
activity. As in earlier studies and unless indicated otherwise, assays
of Na,K-ATPase activity were carried out using 1 mM ATP to
maintain close to saturating ATP concentration and also maximize
sensitivity of assays of the relatively low activity cultured cells
(see Refs. 20, 24, and 25). Na-ATPase activity was measured at 1 µM ATP as described previously (7), with varying amounts
of added KCl and choline chloride to maintain constant chloride (40 mM) concentration, and baseline activity was determined
with 40 mM KCl. For studies of vanadate sensitivity,
inorganic orthovanadate (Fisher) solutions were prepared prior to the
experiment and added with the [
-32P]ATP solution to
initiate the reaction. Na,K-ATPase activities obtained at various
vanadate concentrations and expressed as percentage of that obtained in
the absence of vanadate, were analyzed by fitting the data to a
one-compartment model using a non-linear least-square analysis of a
general logistic function, as described elsewhere (26).
Phosphoenzyme Determination--
Phosphoenzyme levels were
determined as described earlier (25). Briefly, membranes (~0.01
mg/assay) were preincubated with ouabain (20 µM ouabain,
0.4 mM MgSO4, and 10 mM
glycylglycine-Tris (pH 7.4)) for 10 min at 37 °C to inhibit
endogenous HeLa Na,K-ATPase. The suspension was then treated with
either oligomycin (20 µg/ml) for 1 min at room temperature or with
vehicle alone (ethanol) for baseline measurements (see below).
Phosphorylation was then carried out for 10 s at 0 °C in a
final volume of 150 µl in medium comprising (final concentrations)
100 mM NaCl, 10 mM glycylglycine-Tris (pH 7.4),
5 mM EGTA, 1 mM MgSO4, and 1 µM [
-32P]ATP (specific activity
10,000-20,000 cpm/pmol). Baseline EP levels were determined by
replacing 100 mM NaCl with 50 mM KCl and 50 mM choline chloride, and phosphorylating the enzyme in the
absence of oligomycin.
Formation of the E1 from
E2(K+)--
The rate of K+
deocclusion (E2(K+)
E1 + K+) was measured indirectly by determining the rate of
E1 formation from E2(K+) as
described elsewhere (25), with the modifications described by Therien
and Blostein (27).
Rate of E1P
E2P--
Following
formation of E1P in the presence of high chloride
concentration (28), the rate of E1P
E2P was
determined by measuring the rate of disappearance of total
phosphoenzyme following rapid dilution of the salt (to allow normal
relaxation of E1P
E2P) plus addition of KCl
to catalyze rapid hydrolysis of E2P (28, 29). Accordingly,
the enzyme was first phosphorylated in medium containing 600 mM NaCl to stabilize E1P, 1 mM
MgCl2, 1 mM EGTA, and 20 mM
Tris-HCl (pH 7.4) with 1 µM [
-32P]ATP
for 30 s at 0 °C to obtain maximal phosphoenzyme.
Dephosphorylation was then initiated by 6-fold dilution with a chase
medium containing final concentrations of 20 mM KCl, 10 µM unlabeled ATP, 1 mM EGTA, and 20 mM Tris-HCl (pH 7.4), which simultaneously lowered the NaCl
concentration to 100 mM. Samples were taken for measurement of E32P for periods of up to 30 s. Background
phosphoenzyme levels were obtained by allowing the chase to continue
for 60 s.
At least two different membrane preparations obtained from at least two
different clones were assayed. The data presented are representative of
at least three independent experiments. Each value shown is the
mean ± S.D. of triplicate determinations.
 |
RESULTS |
To determine more precisely the structural basis and
mechanism underlying the role of the cytoplasmic N terminus of the
1 catalytic subunit of the Na,K-ATPase on the steady-state E1
E2 conformational poise, we first considered the nature
of the secondary structure of this 85-residue N-terminal domain. This region is a highly charged, flexible structure with a high degree of
helicity. A comparison of the results of several computational analyses
(see "Experimental Procedures") reveals the presence of three
putative
-helical domains encompassing residues 27-33, 42-50 and
61-68 (Fig. 1). To remove or disrupt
these regions, wild type HeLa cells were transfected with N-terminal
deletion mutants of the
1 subunit of the rat Na,K-ATPase
corresponding to either disruption or loss of the first putative helix
(
1M32 and
1M40, respectively) and disruption (
1M46 and
1M49) or loss (
1M56) of the second helix (Fig. 1). All five of
the mutant constructs yielded functional enzyme capable of sustaining
HeLa cell growth in 1 µM ouabain.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 1.
N terminus of the rat
1 Na,K-ATPase and deletion mutants thereof.
Computational analysis of the N-terminal sequence predicts three
helices in the N-terminal of the 1 Na,K-ATPase within, at least,
residues 27-33, 42-50, and 61-68 (for details see "Experimental
Procedures"). Numbering is based on the mature rat 1 amino acid
sequence (60).
|
|
Several criteria were used to analyze shifts in the
E1/E2 distribution: some that reflect the
operation of the overall catalytic cycle and others that reflect
partial reactions relevant to the major E1
E2 and E1P
E2P transitions. The
former include: (i) sensitivity of Na,K-ATPase activity to inhibition
by vanadate, (ii) response of Na-ATPase to varying K+
concentrations relevant to the normally rate-limiting
E2(K+)
E1 + K+,
(iii) catalytic turnover, and (iv) K'ATP relevant to low
affinity ATP binding to E2(K+). The latter
include: (v) rate of K+ deocclusion
[E2(K+)
E2 + K+] (see (ii) above), and (vi) rate of E1P
E2P as outlined in "Experimental Procedures."
Functional Consequences of Deletion Mutants: (i)
Analysis of the Overall Catalytic Cycle under Steady State
Conditions--
Compared with the wild type
1 enzyme, the poise in
E1
E2 of the
1M32 deletion mutant is
notably shifted toward E1 forms of the enzyme (7, 25). To
gain insight into the effects of further deletions on conformational
equilibrium, we investigated the effect of vanadate on Na,K-ATPase
activity. Inorganic orthovanadate is a transition state analog of
inorganic phosphate that binds to P-type ATPases in the E2
conformation (30). Consequently, sensitivity of an enzyme to inhibition
by vanadate is a measure of the proportion of enzyme in the
E2 conformation. As shown by the representative experiment
in Fig. 2 and summarized in Table I,
1M32 and
1M40 are both less
sensitive to vanadate inhibition than is
1, suggesting that the
E1/E2 equilibrium of these enzymes progressively
shifts toward E1 as up to 40 residues are deleted from the N
terminus. However, this shift is reversed to a more wild type-like
sensitivity by deleting
46 residues (mutants
1M46,
1M49, and
1M56).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 2.
Vanadate sensitivity of N-terminal deletion
mutants. ATP hydrolysis at varying vanadate concentrations was
determined with 100 mM NaCl, 10 mM KCl, and 1 mM ATP as described under "Experimental Procedures."
Data are presented as percent Na,K-ATPase (control) measured
in the absence of vanadate. Results shown are from a representative
experiment; shown are mean ± S.D. of triplicate determinations.
Symbols are: , 1 (dashed line); , 1M32; ,
1M40; X, 1M46; , 1M49; , 1M56.
|
|
At micromolar ATP concentrations, sufficient to saturate only the high
affinity phosphorylation site, the response of Na-ATPase to
K+ is a sensitive means to characterize mutant-specific
differences in the K+ deocclusion pathway of the
reaction cycle (E2(K+)
E1 + K+], which becomes rate-limiting under
these conditions (7, 31). Thus, as shown previously and in Fig.
3, K+ inhibits the Na-ATPase
activity of
1 but stimulates that of
1M32. The deletion of 40 residues,
1M40, results in an even greater K+
stimulation, up to ~400%. Interestingly, further deletion,
i.e.
1M46,
1M49, and
1M56, yields
1-like
K+ inhibition. These results, summarized in Table I,
suggest a progressive shift in the E1/E2
conformational equilibrium toward E1 upon removal of up to
40 residues from the N terminus, which is reverted by deleting
46
residues.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 3.
K+ sensitivity of Na-ATPase.
ATP hydrolysis was assayed in the presence of 1 µM ATP,
20 mM NaCl, and various concentrations of KCl as described
under "Experimental Procedures." Data are presented as percent of
Na-ATPase activity (control) measured in the absence of
added KCl. Results shown are from a representative
experiment. Values are the mean ± S.D. of triplicate
determinations. Symbols are as in the legend to Fig. 2.
|
|
The catalytic turnover of the Na,K-ATPase is estimated as the ratio of
VMAX to EPMAX, the latter measured
at 0 °C in the presence of ATP, Na+, and oligomycin to
trap the enzyme in the (Na+)E1P state (see
"Experimental Procedures") (32). Table I shows the catalytic
turnover of
1 and the mutant enzymes. As previously shown,
1M32
has ~50% reduction in turnover, consistent with a shift in the
E1
E2 poise toward E1.
1M40
has a significantly lower turnover, only 20% that of
1. In
contrast, deletion of
46 residues restores the catalytic turnover
to near that of
1.
Differences in K+ sensitivity of Na-ATPase at low ATP
con-centration (Fig. 3) suggest a change in the rate of a step in the K+ deocclusion phase of the Albers-Post reaction mechanism,
which can be modeled by a branched pathway (see Scheme 1 in Ref. 33). In one branch, pathway A, ATP first binds with low affinity
denoted by K'ATP(L), to the K+ occluded enzyme,
followed by rapid deocclusion (ATP·E2(K+)
ATP·E1·K
ATP·E1 + K+). In
the other branch, pathway B, the slow release of
K+ from E2(K+) via
E2(K+)
E1·K+
E1 + K+ is followed by high affinity ATP
binding to E1. Accordingly, a mutation causing a change in
K+ stimulation of Na-ATPase at micromolar ATP concentration
may reflect a change in K'ATP(L) (pathway A)
and/or a change in rate of the second pathway (pathway B).
Fig. 4 shows that both
1M32 and
1M40 have significantly higher apparent affinities for low affinity
ATP binding compared with
1 (see K'ATP(L) values in Table I). In contrast,
1M46 and
1M49 have K'ATP(L)
values similar to that of the wild type
1 enzyme, consistent with
the observed reversal of the K+ effect on Na-ATPase at 1 µM ATP. It was noted, however, that the
K'ATP(L) of
1M56 is lower that that of
1 even though
this enzyme is inhibited by K+ at low ATP. This
characteristic of
1M56 is considered further in the
"Discussion."

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of N-terminal deletions on ATP
dependence of Na,K-ATPase activity. ATP hydrolysis was assayed in
the presence of 100 mM NaCl, 10 mM KCl, 3 mM MgSO4, and varying ATP concentrations as
described under "Experimental Procedures," and normalized to 100%
VMAX. Results are taken from a representative
experiment; shown are the average ± S.D. of triplicate
determinations. Symbols are as in the legend to Fig. 2.
|
|
(ii) Analysis of Partial Reactions Relevant to Conformational
Transitions--
In another series of experiments we compared the slow
release of K+ from E2(K+) via the
branch E2(K+)
E1·K+
E1 + K+ for
each of the mutants. As in our earlier studies (25, 27) we used an
indirect approach whereby the relatively slow rate of E1
formation from E2(K+) is estimated at various
periods following dilution of preformed E2(K+)
in Na+ medium containing [
-32P]ATP at
10 °C. Assuming that the ensuing phosphorylation of E1 is rapid, the amount of phosphoenzyme (presumably Na·E1P
since oligomycin is present to trap this intermediate) is thus a
measure of E1 formed from
E2(K+). As shown in Fig.
5, the changes in
E2(K+) deduced from the increases in
E1P, fit well to single exponentials. The rate constants
for
1M32 and
1M40 shown in Table II
are significantly higher than that of
1. (Rate constants are similar
to our previously published values for
1 and
1M32, Ref. 25). This
result suggests that for both
1M32 and
1M40 the
E2(K+)
E1 + K+
poise is shifted to the right. On the other hand, values for
1M46,
1M49, and
1M56 are similar to, or even lower than, those for
1M32 and
1M40, suggesting that deletion of
46 residues reverses
the above right-shift to a more wild type-like
E1/E2 distribution. It should be noted,
however, that whereas the K+ sensitivity of Na-ATPase at 1 µM ATP reflects overall turnover via both branch pathways
of K+ deocclusion, with the contribution of pathway A
increasing as K'ATP(L) decreases, the time course of
formation of E1 from E2(K+)
reflects only deocclusion via pathway B. It is not known whether changes in each of the two pathways are quantitatively equivalent. They
may not be equivalent. Thus, K+ stimulation of the
Na-ATPase is notably greater for
1M40 compared with
1M32 despite
their similar rates of E2(K+)
E1; K+ inhibition profiles of
1M46 and
1M49 are similar to that of
1, yet their rates of
E2(K+)
E1 are slower than that
of
1. Despite these issues and the fact that this reaction was
analyzed at 10 °C, the generally consistent pattern of increasing
followed by decreasing rates of E2(K+)
E1 associated with progressive deletions, is
noteworthy.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 5.
Rate of formation of E1 from
E2(K+). The rate of K+
deocclusion was measured indirectly as the rate of formation of
E1 from E2(K+) at 10 °C as
described under "Experimental Procedures." Results shown are taken
from a representative experiment; each value is the
mean ± S.D. of triplicate determinations. Symbols are as in the
legend to Fig. 2.
|
|
To investigate the contribution of the conformational transition of the
phosphoenzyme to the E1
E2 shifts observed
above, we examined the E1P
E2P transition
at 0 °C as previously described (28, 29). Accordingly, the enzyme is
first phosphorylated by [
-32P]ATP at high salt
concentration (600 mM NaCl) to stabilize E1P. Dephosphorylation is then initiated by a downward jump in NaCl concentration to 100 mM with the simultaneous addition of
20 mM KCl and 10 µM unlabeled ATP. Since the
rate of K+-activated dephosphorylation of E2P
is much faster than that of the preceding formation of E2P
from E1P, the time course of the E1P decay
reflects primarily E1P
E2P. As shown in
Fig. 6 and summarized in Table II,
compared with the wild type
1 enzyme, the rate of this transition is
~6-fold slower for
1M32 and
1M40. Mutants
1M46,
1M49, and
1M56 have similar or only slightly slower dephosphorylation rates
relative to the wild type enzyme. Taken together, these partial
reaction analyses of the mutants and wild type enzyme reflect the
behavior seen in assays of the overall catalytic cycle summarized in
Table I.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 6.
Rate of formation of
E2P from E1P. The
rate of E1P E2P was measured indirectly at
0 °C as described under "Experimental Procedures." The results
are taken from a representative experiment with mean ± S.D. of
triplicate determinations. Symbols are as in the legend to Fig.
2.
|
|
 |
DISCUSSION |
The primary sequences of the N and C termini are the least
conserved domains among the various P-type ATPases found in lower organisms and throughout the plant and animal kingdom. These
extramembranous termini contain regions that inhibit pump activity, as
well as binding motifs for regulatory proteins that may release pump
inhibition by these auto-inhibitory sequences (34). Examples include
the plasma membrane Ca2+-ATPase, which contains
auto-inhibitory domains in its N terminus in plants or in its C
terminus in animals (35-37). Despite their low homology, a structural
paradigm does exist for the N terminus of P-type ATPases, whereby the
region comprises two domains. These are: (i) a variable domain, which
differs markedly in sequence and length among the ATPases and (ii) a
homologous domain that continues into the S1 stalk region of the N
terminus (38). The variable domain, as the name indicates, varies
greatly in size from the very long termini of metal-transporting
ATPases such as the Cu-ATPase (39, 40) to being virtually absent in the sarcoplasmic reticulum Ca2+-ATPase
(SERCA).1 The homologous
domain consists of about 33 amino acids and has a high propensity to
form two short helices in H,K-ATPase, SERCA, and Na,K-ATPase (38),
which, in the latter pump, comprises helices H2 and H3 described below.
The N terminus of the Na,K-ATPase is a highly charged and flexible
structure, with a high degree of helicity (see Fig. 1). Although the
primary sequence of this region diverges greatly among isoforms and
species, the following features persist: (i) a lysine-rich cluster of
about 5-9 residues and (ii) a highly conserved 10 amino acid sequence
circumscribed by two methionines (M(D/E)ELKKE(I/V)(S/T)M) (41) and
containing a proteolytically sensitive lysine residue (5).
In his landmark studies, Jorgensen showed that the lysine-rich domain
of the N terminus of the Na,K-ATPase precedes a proteolytically sensitive site (T2) that can be selectively cleaved by trypsin when the
enzyme is in the E1 conformation (5, 6). Cleavage at this
residue increases K'K and decreases K'ATP, with
associated effects on the phosphorylation and dephosphorylation
reactions of the enzyme (42-44), providing evidence for a shift in the
E1/E2 equilibrium toward E1 forms
(45, 46). Several studies have demonstrated that although the lysine
cluster is not essential to pump function (47-51), the N terminus may
play a role in Na+ sensitivity (52), K+
affinity, and in the dependence on membrane potential (53, 54) likely
resulting from changes in rates of Na+ translocation (41)
and K+ deocclusion reactions (55).
We have previously shown that deletion of up to 27 residues
preceding the first putative helix has no effect on the conformational equilibrium of the enzyme (7, 8, 25). Only upon deletion of 32 residues, which corresponds to T2 described above, is there a shift
toward E1 (8, 25). Here we show that disruption (
1M32) or loss (
1M40) of H1 results in a progressive shift toward
E1 forms of the enzyme. We also show that disruption
(
1M46 and
1M49) or loss (
1M56) of H2 (as well as H1) reverses
the shift to a more wild type-like E1
E2 equilibrium.
The aforementioned progressive changes notwithstanding, the
behavior of
1M56 is slightly peculiar. Unlike
1M46 and
1M49,
1M56 retained a lower K'ATP(L) even though all three
mutants resemble wild type
1 with respect to the following: (i)
vanadate sensitivity, (ii) sensitivity to K+ inhibition at
low ATP, (iii) rate of E1 formation from
E2(K+), and (iv) rate of E1P
E2P. These observations may indicate some change or
destabilization of structure that occurs with extensive truncation. For
example, truncation beyond the first 49 residues may perturb a
heretofore undefined interaction of the N terminus with another region,
which may cause ligand-specific effects independent of the
conformational transitions, such as an increased access of nucleotide
substrate to the binding site.
Cytoplasmic Interactions Involved in Conformational
Transitions--
Insights into cytoplasmic region(s) that interact
with the N terminus were first obtained by Jorgensen and Collins (56) who proposed salt-bridge formation between the N terminus and other
cytoplasmic domains. In a later study (8), the remarkable synergistic
effects of the
32 deletion and the E233K mutation implicated the N
terminus/M2-M3 loop in such a salt-bridge formation. It is noteworthy
that the cytoplasmic region encompassing the N terminus/M2-M3 loop is
analogous to the Activator or A domain identified in the crystal
structure of SERCA1a (57). In the Na,K-ATPase, interaction of the A
domain with the catalytic loop was observed in the studies of Karlish
and co-workers who used metal catalyzed cleavage to study domain
interactions of the Na,K-ATPase in E1 versus
E2 conformations (for review, see Ref. 58). Accordingly, in
the E1 conformation, the nucleotide binding domain in the
catalytic M4-M5 loop docks onto the phosphorylation domain in M4-M5,
and domain A moves aside. In E2(K+), domain A
docks onto the phosphorylation domain, and the nucleotide binding
domain is displaced. It is noteworthy that all of the data are
consistent with the published SERCA1a crystal structure and with
further structural evidence that E1
E2P
transitions of SERCA involve large domain movements (57). The emerging
picture is that the structural changes underlying conformational
transitions are generally similar for SERCA and the Na,K-ATPase, and
much can be extrapolated about their analogous structures (for a
detailed comparison, see Ref. 59). A main structural distinction is the N terminus, which is encompassed by domain A. In SERCA, the N terminus
is a much shorter extension from the M1 transmembrane helix, lacking
the first helical domain, and that which remains has a uniquely
different primary sequence from that of the Na,K-ATPase.
The Distinct Modulatory Role of the N Terminus of the
Na,K-ATPase--
The present mutagenesis study reveals a specific role
of the N terminus of the Na,K-ATPase. The model shown in Fig.
7 depicts a region of the N terminus that
acts as an autoregulatory domain modulating the
E1/E2 conformational transitions. In the case
of the wild type enzyme (Fig. 7, panel A), helical region H2
can interact with H1 either through helix-helix interactions and/or salt-bridge formation in the E2 conformation, allowing the
M2-M3 loop and the catalytic loop to come together (shaded
ovals). H2 can also interact with a domain of the M2-M3 loop in
E1 to keep it apart from the catalytic loop as in the
E1 conformation. When H1 is disrupted or lost (
1M32 or
1M40, see Fig. 7, panel B), H2 preferentially interacts
with the M2-M3 loop, placing a constraint on the latter, thereby
weakening the M2-M3/M4-M5 interaction and consequently stabilizing the
E1 conformation. The result is a shift in the
conformational equilibrium in favor of E1. Lastly, the
disruption (
1M46 and
1M49) or loss of H2 (
1M56) (see Fig. 7,
panel C) alleviates the constraint on the M2-M3 loop
allowing it once again to freely interact with the large catalytic
M4-M5 loop, thus resembling the wild type
1 enzyme.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 7.
Hypothetical model for N-terminal regulation
of conformational equilibrium. Based on evidence from earlier work
and the present study, a model is proposed whereby an autoregulatory
region of the N terminus modulates the poise in E1 E2. For details see "Discussion."
|
|
It is also noteworthy that the
2 and
3 isoforms of the catalytic
subunit of the rat Na,K-ATPase have similar helical structures in their
N termini. Furthermore, analogous disruptions of the first helix of
2 and
3 (mutants
2M30 and
3M26,
respectively)2 shift the
conformational equilibrium for each enzyme toward E1 forms,
suggesting that the N terminus of the Na,K-ATPase may carry an
autoregulatory domain present in all three isoforms.
In conclusion, we have identified an autoregulatory domain within
the N terminus of the sodium pump, which modulates conformational transitions, suggesting novel intramolecular interactions within the
cytoplasmic domains of the enzyme. Studies are currently underway to
further pinpoint the residues in the N terminus that are involved in
these interactions.
 |
ACKNOWLEDGEMENTS |
We thank Zahid Z. Javaid for preparation of
the
1M40 and
1M56 constructs and Dr. Alex Therien for helpful
discussions and critical reading of the manuscript. The excellent
technical assistance of Rosemarie Scanzano is gratefully acknowledged.
 |
FOOTNOTES |
*
This work was supported by operating grants from the
Canadian Institutes of Health Research (Grant MT-3876) and the Quebec Heart and Stroke Foundation (to R. B.), the National Institutes of
Health (Grant HL 49204) (to L. K.), and a predoctoral fellowship from
the Heart and Stroke Foundation of Canada (to L. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Montreal General
Hospital Research Inst., 1650 Cedar Ave., Rm. L11-132, Montreal, Quebec
H3G 1A4, Canada. Tel.: 514-934-1934 (ext. 44501); Fax: 514-934-8332;
E-mail: Rhoda.Blostein@mcgill.ca.
Published, JBC Papers in Press, July 10, 2002, DOI 10.1074/jbc.M206115200
2
L. Segall, S. E. Daly, and R. Blostein,
unpublished observation.
 |
ABBREVIATIONS |
The abbreviation used is:
SERCA, sarcoplasmic
reticulum Ca2+-ATPase.
 |
REFERENCES |
| 1.
|
Sweadner, K. J.
(1989)
Biochim. Biophys. Acta
988,
185-220[Medline]
[Order article via Infotrieve]
|
| 2.
|
Lingrel, J. B.,
and Kuntzweiler, T.
(1994)
J. Biol. Chem.
269,
19659-19662[Free Full Text]
|
| 3.
|
Mercer, R. W.,
Biemesderfer, D.,
Bliss, D. P., Jr.,
Collins, J. H.,
and Forbush, B. 3 rd.
(1993)
J. Cell Biol.
121,
579-586[Abstract/Free Full Text]
|
| 4.
|
Therien, A. G.,
and Blostein, R.
(2000)
Am. J. Physiol.
279,
C541-66
|
| 5.
|
Jorgensen, P. L.
(1975)
Biochim. Biophys. Acta
401,
399-415[Medline]
[Order article via Infotrieve]
|
| 6.
|
Jorgensen, P. L.
(1977)
Biochim. Biophys. Acta
466,
97-108[Medline]
[Order article via Infotrieve]
|
| 7.
|
Daly, S. E.,
Lane, L. K.,
and Blostein, R.
(1994)
J. Biol. Chem.
269,
23944-23948[Abstract/Free Full Text]
|
| 8.
|
Boxenbaum, N.,
Daly, S. E.,
Javaid, Z. Z.,
Lane, L. K.,
and Blostein, R.
(1998)
J. Biol. Chem.
273,
23086-23092[Abstract/Free Full Text]
|
| 9.
|
Frishman, D.,
and Argos, P.
(1996)
Prot. Engin.
9,
133-142[Abstract/Free Full Text]
|
| 10.
|
Baldi, P.,
Brunak, S.,
Frasconi, P.,
Soda, G.,
and Pollastri, G.
(1999)
Bioinformatics
15,
937-946[Abstract/Free Full Text]
|
| 11.
|
Geourjon, C.,
and Deleage, G.
(1995)
Comp. Appl. Biosci.
11,
681-684[Abstract/Free Full Text]
|
| 12.
|
Garnier, J.,
Gibrat, J. F.,
and Robson, B.
(1996)
Methods Enzymol.
266,
540-553[Medline]
[Order article via Infotrieve]
|
| 13.
|
Deleage, G.,
and Roux, B.
(1987)
Prot. Engin.
1,
289-294[Abstract/Free Full Text]
|
| 14.
|
Levitt, M.
(1978)
Biochemistry
17,
4277-4285[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Chou, P. Y.,
and Fasman, G. D.
(1978)
Adv. Enzymol. Rel. Areas Mol. Biol.
47,
45-148[Medline]
[Order article via Infotrieve]
|
| 16.
|
Lupas, A.,
Van Dyke, M.,
and Stock, J.
(1991)
Science
252,
1162-1164[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Stultz, R.,
Nambudripad, R.,
Lathrop, R. H.,
and White, J. V.
(1997)
in
Protein Structural Biology in Bio-Medical Research
(Allewell, N.
, and Woodward, C., eds), Vol. 22B
, pp. 447-506, JAI Press, Greenwich
|
| 18.
|
Chen, C.,
and Okayama, H.
(1987)
Mol. Cell. Biol.
7,
2745-2752[Abstract/Free Full Text]
|
| 19.
|
Jewell, E. A.,
and Lingrel, J. B.
(1991)
J. Biol. Chem.
266,
16925-16930[Abstract/Free Full Text]
|
| 20.
|
Lane, L. K.,
Feldmann, J. M.,
Flarsheim, C. E.,
and Rybczynski, C. L.
(1993)
J. Biol. Chem
268,
17930-17934[Abstract/Free Full Text]
|
| 21.
|
Arguello, J. M.,
and Lingrel, J. B.
(1995)
J. Biol. Chem.
270,
22764-22771[Abstract/Free Full Text]
|
| 22.
|
Markwell, M. A.,
Haas, S. M.,
Tolbert, N. E.,
and Bieber, L. L.
(1981)
Methods Enzymol.
72,
296-303[Medline]
[Order article via Infotrieve]
|
| 23.
|
Blostein, R.
(1988)
Methods Enzymol.
156,
171-178[Medline]
[Order article via Infotrieve]
|
| 24.
|
Munzer, J. S.,
Daly, S. E.,
Jewell-Motz, E. A.,
Lingrel, J. B.,
and Blostein, R.
(1994)
J. Biol. Chem.
269,
16668-16676[Abstract/Free Full Text]
|
| 25.
|
Daly, S. E.,
Lane, L. K.,
and Blostein, R.
(1996)
J. Biol. Chem.
271,
23683-23689[Abstract/Free Full Text]
|
| 26.
|
DeLean, A.,
Munson, P. J.,
and Rodbard, D.
(1978)
Am. J. Physiol.
235,
E97-102[Abstract/Free Full Text]
|
| 27.
|
Therien, A. G.,
and Blostein, R.
(1999)
Am. J. Physiol.
277,
C891-8[Abstract/Free Full Text]
|
| 28.
|
Klodos, I.,
Post, R. L.,
and Forbush, B., 3rd.
(1994)
J. Biol. Chem.
269,
1734-1743[Abstract/Free Full Text]
|
| 29.
|
Vilsen, B.
(1997)
Biochemistry
36,
13312-13324[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Cantley, L. C., Jr.,
Cantley, L. G.,
and Josephson, L.
(1978)
J. Biol. Chem.
253,
7361-7368[Free Full Text]
|
| 31.
|
Post, R. L.,
Hegyvary, C.,
and Kume, S.
(1972)
J. Biol. Chem.
247,
6530-6540[Abstract/Free Full Text]
|
| 32.
|
Esmann, M.,
and Skou, J. C.
(1985)
Biochem. Biophys. Res. Commun.
127,
857-863[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Sachs, J. R.
(1994)
Biochim. Biophys. Acta
1193,
199-211[Medline]
[Order article via Infotrieve]
|
| 34.
|
Palmgren, M. G.,
and Axelsen, K. B.
(1998)
Biochim. Biophys. Acta
1365,
37-45[Medline]
[Order article via Infotrieve]
|
| 35.
|
Harper, J. F.,
Hong, B.,
Hwang, I.,
Guo, H. Q.,
Stoddard, R.,
Huang, J. F.,
Palmgren, M. G.,
and Sze, H.
(1998)
J. Biol. Chem.
273,
1099-1106[Abstract/Free Full Text]
|
| 36.
|
Malmstrom, S.,
Askerlund, P.,
and Palmgren, M. G.
(1997)
FEBS Lett.
400,
324-328[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Penniston, J. T.,
and Enyedi, A.
(1998)
J. Membr. Biol.
165,
101-109[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Moller, J. V.,
Juul, B.,
and le Maire, M.
(1996)
Biochim. Biophys. Acta
1286,
1-51[Medline]
[Order article via Infotrieve]
|
| 39.
|
Vulpe, C.,
Levinson, B.,
Whitney, S.,
Packman, S.,
and Gitschier, J.
(1993)
Nat. Genet
3,
7-13[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Bull, P. C.,
Thomas, G. R.,
Rommens, J. M.,
Forbes, J. R.,
and Cox, D. W.
(1993)
Nat. Genet.
5,
327-337[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Wang, X.,
Jaisser, F.,
and Horisberger, J. D.
(1996)
J. Physiol.
491,
579-594[Medline]
[Order article via Infotrieve]
|
| 42.
|
Jorgensen, P. L.,
and Klodos, I.
(1978)
Biochim. Biophys. Acta
507,
8-16[Medline]
[Order article via Infotrieve]
|
| 43.
|
Jorgensen, P. L.,
Skriver, E.,
Hebert, H.,
and Maunsbach, A. B.
(1982)
Ann. N. Y. Acad. Sci.
402,
207-225[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Jorgensen, P. L.,
and Petersen, J.
(1985)
Biochim. Biophys. Acta
821,
319-333[Medline]
[Order article via Infotrieve]
|
| 45.
|
Jorgensen, P. L.,
and Karlish, S. J.
(1980)
Biochim. Biophys. Acta
597,
305-317[Medline]
[Order article via Infotrieve]
|
| 46.
|
Jorgensen, P. L.,
and Andersen, J. P.
(1988)
J. Membr. Biology
103,
95-120[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Shanbaky, N. M.,
and Pressley, T. A.
(1994)
Am. J. Physiol.
267,
C590-597[Abstract/Free Full Text]
|
| 48.
|
Ohta, T.,
Noguchi, S.,
Nakanishi, M.,
Mutoh, Y.,
Hirata, H.,
Kagawa, Y.,
and Kawamura, M.
(1991)
Biochim. Biophys. Acta
1059,
157-164[Medline]
[Order article via Infotrieve]
|
| 49.
|
Burgener-Kairuz, P.,
Horisberger, J. D.,
Geering, K.,
and Rossier, B. C.
(1991)
FEBS Lett.
290,
83-86[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Mutoh, Y.,
Noguchi, S.,
Ohta, T.,
Higashi, K.,
Takasugi, M.,
Kuroiwa, A.,
and Kawamura, M.
(1992)
Biochem. Intl.
26,
775-785[Medline]
[Order article via Infotrieve]
|
| 51.
|
Baxter-Lowe, L. A.,
Guo, J. Z.,
Bergstrom, E. E.,
and Hokin, L. E.
(1989)
FEBS Lett.
257,
181-187[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Ishii, T.,
Lemas, M. V.,
and Takeyasu, K.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
6103-6107[Abstract/Free Full Text]
|
| 53.
|
Vasilets, L. A.,
Omay, H. S.,
Ohta, T.,
Noguchi, S.,
Kawamura, M.,
and Schwarz, W.
(1991)
J. Biol. Chem.
266,
16285-16288[Abstract/Free Full Text]
|
| 54.
|
Vasilets, L. A.,
Ohta, T.,
Noguchi, S.,
Kawamura, M.,
and Schwarz, W.
(1993)
Eur. Biophys. J.
21,
433-443[Medline]
[Order article via Infotrieve]
|
| 55.
|
Wierzbicki, W.,
and Blostein, R.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
70-74[Abstract/Free Full Text]
|
| 56.
|
Jorgensen, P. L.,
and Collins, J. H.
(1986)
Biochim. Biophys. Acta
860,
570-576[Medline]
[Order article via Infotrieve]
|
| 57.
|
Toyoshima, C.,
Nakasako, M.,
Nomura, H.,
and Ogawa, H.
(2000)
Nature
405,
647-655[CrossRef][Medline]
[Order article via Infotrieve]
|
| 58.
|
Goldshleger, R.,
Patchornik, G.,
Shimon, M. B.,
Tal, D. M.,
Post, R. L.,
and Karlish, S. J.
(2001)
J. Bioenerg. Biomembr.
33,
387-399[CrossRef][Medline]
[Order article via Infotrieve]
|
| 59.
|
Sweadner, K. J.,
and Donnet, C.
(2001)
Biochem. J.
356,
685-704[CrossRef][Medline]
[Order article via Infotrieve]
|
| 60.
|
Shull, G. E.,
Greeb, J.,
and Lingrel, J. B.
(1986)
Biochemistry
25,
8125-8132[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles: